Organization Statistics
Avg Compliance Rate
48.60%
Compliant Trials
486
Incompliant submissions
514
Total Organizations
46697
Total trials
1000
Filter Organizations
Compare Organization Compliance Rates
Showing 1650 of 46697 entries
View as:
0.0% Compliant
Total: 1
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 2
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 1
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 1
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 1
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 1
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 1
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 2
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 1
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 1
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 1
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 1
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 1
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 1
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 3
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 1
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 4
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 1
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 5
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 1
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 2
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 1
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 2
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 1
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 1
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
| Sponsor | Funding Source | Total Trials | Reporting Rate | Compliant Trials | Late Submissions | Compliance Rate | Wilson LCB Score | Email Domain | Created Date |
|---|---|---|---|---|---|---|---|---|---|
| Alejandro Gonzalez-Ojeda | - | 1 | 0.0% | 0 | 0 | 0.0% | - | Alejandro Gonzalez-Ojeda.temp.org | 2025-07-14 |
| Alejandro Hoberman | - | 2 | 0.0% | 0 | 0 | 0.0% | - | Alejandro Hoberman.temp.org | 2025-07-14 |
| Alejandro Krolewiecki | - | 1 | 0.0% | 0 | 0 | 0.0% | - | Alejandro Krolewiecki.temp.org | 2025-07-14 |
| Alejandro Lizaur-Utrilla, PhD, MD | - | 1 | 0.0% | 0 | 0 | 0.0% | - | Alejandro Lizaur-Utrilla, PhD, MD.temp.org | 2025-07-14 |
| Alejandro Lucia | - | 1 | 0.0% | 0 | 0 | 0.0% | - | Alejandro Lucia.temp.org | 2025-07-14 |
| Alejandro Muñoz López | - | 1 | 0.0% | 0 | 0 | 0.0% | - | Alejandro Muñoz López.temp.org | 2025-07-14 |
| Alejandro Reyes Sánchez | - | 1 | 0.0% | 0 | 0 | 0.0% | - | Alejandro Reyes Sánchez.temp.org | 2025-07-14 |
| Alejandro Rodriguez Oviedo , MD | - | 2 | 0.0% | 0 | 0 | 0.0% | - | Alejandro Rodriguez Oviedo , MD.temp.org | 2025-07-14 |
| Aleksandar Sovtic | - | 1 | 0.0% | 0 | 0 | 0.0% | - | Aleksandar Sovtic.temp.org | 2025-07-14 |
| Aleksander Krag | - | 1 | 0.0% | 0 | 0 | 0.0% | - | Aleksander Krag.temp.org | 2025-07-14 |
| Aleksandra Eriksen Isham | - | 1 | 0.0% | 0 | 0 | 0.0% | - | Aleksandra Eriksen Isham.temp.org | 2025-07-14 |
| Aleksandra Kiper | - | 1 | 0.0% | 0 | 0 | 0.0% | - | Aleksandra Kiper.temp.org | 2025-07-14 |
| Aleksandra Novakov Mikic | - | 1 | 0.0% | 0 | 0 | 0.0% | - | Aleksandra Novakov Mikic.temp.org | 2025-07-14 |
| Aleksandra Stark | - | 1 | 0.0% | 0 | 0 | 0.0% | - | Aleksandra Stark.temp.org | 2025-07-14 |
| Alembic Pharmaceuticals Ltd. | - | 3 | 0.0% | 0 | 0 | 0.0% | - | Alembic Pharmaceuticals Ltd..temp.org | 2025-07-14 |
| Alen Greš | - | 1 | 0.0% | 0 | 0 | 0.0% | - | Alen Greš.temp.org | 2025-07-14 |
| Alentis Therapeutics AG | - | 4 | 0.0% | 0 | 0 | 0.0% | - | Alentis Therapeutics AG.temp.org | 2025-07-14 |
| Aleor Dermaceuticals Limited | - | 1 | 0.0% | 0 | 0 | 0.0% | - | Aleor Dermaceuticals Limited.temp.org | 2025-07-14 |
| Alere San Diego | - | 5 | 0.0% | 0 | 0 | 0.0% | - | Alere San Diego.temp.org | 2025-07-14 |
| Aleris Eye | - | 1 | 0.0% | 0 | 0 | 0.0% | - | Aleris Eye.temp.org | 2025-07-14 |
| Aleris Helse | - | 2 | 0.0% | 0 | 0 | 0.0% | - | Aleris Helse.temp.org | 2025-07-14 |
| Aleris Hospital | - | 1 | 0.0% | 0 | 0 | 0.0% | - | Aleris Hospital.temp.org | 2025-07-14 |
| Aleris Obesity | - | 2 | 0.0% | 0 | 0 | 0.0% | - | Aleris Obesity.temp.org | 2025-07-14 |
| Aleris-Hamlet Hospitaler København | - | 1 | 0.0% | 0 | 0 | 0.0% | - | Aleris-Hamlet Hospitaler København.temp.org | 2025-07-14 |
| Alesi Surgical Ltd. | - | 1 | 0.0% | 0 | 0 | 0.0% | - | Alesi Surgical Ltd..temp.org | 2025-07-14 |